AstraZeneca PLC (AZN) Presents at American Society for Bone and Mineral Research (ASBMR) 2026 Annual Meeting - Slideshow

AstraZeneca presents at the American Society for Bone and Mineral Research (ASBMR) 2026 Annual Meeting. The company presented data on its osteoporosis drug, romosozumab.

The drug has shown promising results in clinical trials, with a significant reduction in fractures.

AstraZeneca's stock price has increased by 20% in the past year.